Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31581174.
- Also identified by DOI 10.1038/s41586-019-1660-y and PMC identifier 7014971.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival<sup>1-3</sup>. RAF activity is tightly regulated and inappropriate activation is a frequent cause of cancer<sup>4-6</sup>; however, the structural basis for RAF regulation is poorly understood at present. Here we use cryo-electron microscopy to determine autoinhibited and active-state structures of full-length BRAF in complexes with MEK1 and a 14-3-3 dimer. The reconstruction reveals an inactive BRAF-MEK1 complex restrained in a cradle formed by the 14-3-3 dimer, which binds the phosphorylated S365 and S729 sites that flank the BRAF kinase domain. The BRAF cysteine-rich domain occupies a central position that stabilizes this assembly, but the adjacent RAS-binding domain is poorly ordered and peripheral. The 14-3-3 cradle maintains autoinhibition by sequestering the membrane-binding cysteine-rich domain and blocking dimerization of the BRAF kinase domain. In the active state, these inhibitory interactions are released and a single 14-3-3 dimer rearranges to bridge the C-terminal pS729 binding sites of two BRAFs, which drives the formation of an active, back-to-back BRAF dimer. Our structural snapshots provide a foundation for understanding normal RAF regulation and its mutational disruption in cancer and developmental syndromes.
Medical subject headings
- 14-3-3 Proteins
- Cryoelectron Microscopy
- MAP Kinase Kinase 1
- Proto-Oncogene Proteins B-raf